分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Improvement and engineering of methionine γ-lyase from Pseudomonas deceptionensis based on molecular dynamics simulation and adaptive analysis for anti-tumor applications

Lili Wu, Sen Zou, Xuemin Li, Qin Fang, Qun Dai, Jing Tian

Journal:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF:8.7

DOI:10.1016/j.ijbiomac.2026.150570

PMID:41605391

Published:2026-01-27

research field:催化分析化学纳米技术生物化学

Abstract

Methionine γ-lyase (MGL) is a pyridoxal-5′-phosphate–dependent enzyme with strong potential as an anticancer therapeutic, yet its poor catalytic efficiency, low stability, and high immunogenicity limit clinical application. In this study, molecular dynamics (MD) simulations were employed to identify highly flexible regions of Pseudomonas deceptionensis MGL (PdMGL), revealing the C-terminal loop near the catalytic pocket and the N-terminal region as hotspots of conformational instability. These flexible segments, together with global fitness landscape predictions, were further optimized using the deep-learning-based protein language model ESM-2 to guide rational mutagenesis. Activity screening revealed several beneficial single mutations, including H368A, K4S, Y190F, and N163T, and subsequent iterative recombination produced the quadruple mutant K4S-N163T-Y190F-H368A. This optimized variant exhibited a 3.8-fold increase in activity, over fourfold improvement in catalytic efficiency, enhanced plasma stability, and superior cytotoxicity against colorectal cancer cells, with IC 50 values reduced by more than an order of magnitude compared to wild type. These findings validate the synergy of MD simulations and protein language models in therapeutic enzyme engineering and establish K4S-N163T-Y190F-H368A as a promising candidate for anticancer applications.

本文使用的Yeasen产品

购物车
客服
转染试用